singapore dahua fund came to "eagle jun pharmaceutical" to carry out investment investigation-最新凯时注册

in march, ludao fangfei. on march 30, 2016, singapore uob fund arrived in xiamen yingjun pharmaceutical for an investment inspection, and visited yingjun pharmaceutical’s 4,500 square meters of intelligent natural medicine research hall and 28,000 square meters of modern ecological health care products. after the gmp manufacturing base, the r&d and innovation capabilities of yingjun pharmaceutical were highly evaluated and affirmed. great eagle pharmaceuticals has two major funds, including the morgan group of the united states, and idc capital of australia and uob capital of singapore. yingjun pharmaceutical will make persistent efforts and continue to expand new paths for the internationalization of chinese medicine.